WASHINGTON, D.C., (June 9, 2011) — In an effort to protect patient access to osteoporosis testing and reduce the physical and economic burden of osteoporosis for millions of Americans, Senators Olympia Snowe (R-ME) and Debbie Stabenow (D-MI) and Representatives Michael Burgess (R-26-TX) and Shelley Berkley (D-1-NV) introduced in Congress the “Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011” (S. 1096 and H.R. 2020).
WASHINGTON, D.C., (June 9, 2011) — In an effort to protect patient access to osteoporosis testing and reduce the physical and economic burden of osteoporosis for millions of Americans, Senators Olympia Snowe (R-ME) and Debbie Stabenow (D-MI) and Representatives Michael Burgess (R-26-TX) and Shelley Berkley (D-1-NV) introduced in Congress the “Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011” (S. 1096 and H.R. 2020).
On May 26, 2011, the National Osteoporosis Foundation (NOF), along with 22 other patient, professional, health and community organizations sent a letter to Senators Snowe and Stabenow, and Representatives Burgess and Berkley, thanking them for introducing S. 1096/H.R. 2020.
Download the House letter.
Download the Senate letter.
WASHINGTON — On Thursday, May 12, Senator Kirsten E. Gillibrand of New York introduced in the Senate the “Bone Health Promotion and Research Act of 2011” (S.
In this session, Dr. Khosla will explore the future of osteoporosis therapies including new pathways under investigation and other promising therapeutic agents in development.
Estrogen plays a key role in building and maintaining bone in both men and women. Other sex hormones will be discussed as well to show the different effects each has in the body. It may be possible to use levels of follicle stimulating hormone (FSH) in the blood as a marker to estimate the degree of bone loss during menopause.
Osteoporosis is a disease characterized by weakened and fragile bone tissue, leading to an increased chance of breaking a bone. The weakened tissue is due to changes in the amount and structure of bone. While people with osteoporosis are most likely to break bones in the spine, hip or wrist, almost any bone can be affected. These bone breaks often occur with minor accidents such as falls, or banging into objects, but can even occur after no accident at all.
HHS' Agency for Healthcare Research and Quality (AHRQ) would like to make you aware of a new report on hip fracture pain and management. This new Federal report concludes most treatments to relieve pain for patients who suffer a broken hip work at least in the short term, but finds a lack of evidence supporting one treatment over another. In addition, the report highlights an overall lack of high-quality data and evidence.
WASHINGTON, DC (May 12, 2011) – A faculty of internationally-renowned osteoporosis experts are gathering next week to share the latest clinically-relevant information on osteoporosis prevention, diagnosis and treatment at the National Osteoporosis Foundation’s (NOF) 9th International Symposium on Osteoporosis (ISO9): Translating Research Into Clinical Practice, May 18 -21 at The Cosmopolitan™ of Las Vegas in Las Vegas, NV. Held annually, ISO9 aims to bridge the gap between osteoporosis research and its application in clinical practice.
Washington, DC - May 3, 2011 - To launch National Osteoporosis Awareness and Prevention Month on Capitol Hill, NOF hosted a congressional briefing on May 3, 2011. Congressional staff heard from a patient, a caregiver, and health professionals about the importance of strong bones to overall health.


WASHINGTON, DC (May 5, 2011) – The National Osteoporosis Foundation (NOF) will honor Mercedes Ellington, dancer, choreographer and granddaughter of “Duke” Ellington, at its Silhouette Awards Dinner on Thursday, May 19 at The Cosmopolitan™ of Las Vegas. Other honorees include Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Stephen I. Katz, M.D., Ph.D.; C. Conrad Johnston, Jr., M.D. of the Indiana University School of Medicine; and patient advocate, Sally Fullman, Ph.D.